Recurrence-free survival after curative resection of non-small cell lung cancer between inhalational gas anesthesia and propofol-based total intravenous anesthesia: a multicenter, randomized, clinical trial (GAS TIVA trial): protocol description
Kim J, Yoon S, Song I, Lee K, Hwang W, Kim H, Lee D, Lim H, Kim S, Lee J, Hong B, Blank R, Pedoto A, Popescu W, Theresa G, Martin A, Patteril M, Pathanasethpong A, Thongsuk Y, Pisitpitayasaree T, Huang A, Yu H, Kapoor P, Kim K, Chi S, Ahn H. Recurrence-free survival after curative resection of non-small cell lung cancer between inhalational gas anesthesia and propofol-based total intravenous anesthesia: a multicenter, randomized, clinical trial (GAS TIVA trial): protocol description. Perioperative Medicine 2024, 13: 79. PMID: 39039548, PMCID: PMC11264408, DOI: 10.1186/s13741-024-00436-1.Peer-Reviewed Original ResearchNon-small cell lung cancerRecurrence-free survivalCurative resection of non-small cell lung cancerResection of non-small cell lung cancerCell lung cancerCurative resectionTotal intravenous anesthesiaPropofol-based total intravenous anesthesiaLung cancerRandomized trialsClinical trialsAnesthetic managementReducing cancer recurrence riskAmerican Society of Anesthesiologists physical statusPatient's written informed consentMicroscopic residual diseaseInstitutional review board approvalReduce tumor recurrenceLung resection surgeryMethodsThis double-blindInhibit tumor angiogenesisMulticenter randomized trialCancer recurrence riskCell-mediated immunityIntravenous anesthesia